SPC437
Etranacogene dezaparvovec (an adeno-associated viral vector containing a codon-optimized Padua derivative of human coagulation factor IX gene for the treatment of hemophilia B)
Status:
UmsóknApplication date:
25.7.2023Application published:
15.8.2023
Max expiry date:
14.9.2034Medicine name:
HemgenixMedicine for children:
No
Timeline
Today
25.7.2023Application
15.8.2023Publication
14.9.2034Expires
Marketing license
IS authorization number:
EU/1/22/1715Date:
22.3.2023
Foreign authorization number:
EU/1/22/1715/001Date:
20.2.2023
Owner
Name:
uniQure biopharma B.V.Address:
Paasheuvelweg 25a, 1105 BP Amsterdam NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3581650